• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. LVIS JR 3.5X18 MM; STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. LVIS JR 3.5X18 MM; STENT Back to Search Results
Model Number 172516-CASJ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombus (2101)
Event Date 10/26/2018
Event Type  Injury  
Manufacturer Narrative
The lot number was not provided; therefore, a search for production-related ncrs could not be performed.The stent was implanted in the patient and the remainder of the device was not returned to the manufacturer; therefore, a product analysis could not be performed.The root cause is unknown.The instructions for use (ifu) identifies thrombus as a potential complication associated with use of the device.
 
Event Description
It was reported that on (b)(6) 2018, the patient was treated for a saccular aneurysm located in the internal carotid artery (supraclinoid segment), the patient's pre-procedure was mrs=0.The aneurysm had never ruptured and had been previously treated with coils.During the procedure, thrombus developed within the lvis jr.Stent, which gradually worsened.The thrombus was treated with reopro and an additional endovascular procedure (thrombectomy) was performed using a hyperglide balloon and a solitaire stentriever.Final angiography demonstrated a complete occlusion of the aneurysmal sac.The event was reported to be resolved without sequelae on the same day as the procedure.The event was classified as being without seriousness, with mild severity, and in terms of clinical impact, the patient was asymptomatic.Neurological evaluation of the patient at hospital discharge was mrs=1.At the 6-month follow-up visit on (b)(6) 2019, the neurological evaluation of the patient was mrs=0.Imaging demonstrated a complete and stable occlusion of the aneurysm and the parent artery remains without stenosis.The patient is enrolled in the lepi clinical trial and will be closely monitored per study protocol.
 
Manufacturer Narrative
Additional information provided in medical records received from the clinical site indicates that the lvis jr had been placed across the wide-necked aneurysm in the left m1 segment and in the termination of the left internal carotid artery to assist with coil implantation.The patient was prescribed dual antiplatelet therapy with plavix and kardegic for a minimum of 6 months, post-procedure.A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LVIS JR 3.5X18 MM
Type of Device
STENT
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise drive
aliso viejo CA 92656
MDR Report Key8952740
MDR Text Key156873340
Report Number2032493-2019-00208
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
P170013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date05/31/2020
Device Model Number172516-CASJ
Device Lot Number17060651A
Was Device Available for Evaluation? No
Date Manufacturer Received08/02/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PROWLER 10 MICROCATHETER
Patient Outcome(s) Required Intervention;
Patient Age48 YR
-
-